Mouse cDC1 are highly efficient in antigen cross-presentation, i.e., the presentation of extracellular antigens by MHC I molecules, and therefore are critical at priming CD8+ T cell responses to exogenous tumor antigen [36]. The gene discussed is CD8A; the disease is neoplasm.